UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

S3307 Unmet Need of an Oral Treatment in Moderate to Severe Ulcerative Colitis: Findings From International Patient and Physician Survey

The American journal of gastroenterology, 2021-10, Vol.116 (1), p.S1363-S1363

2021

Volltextzugriff (PDF)

S17 Treatment Patterns Among Moderate-to-Severe Ulcerative Colitis Patients in TARGET-IBD

The American journal of gastroenterology, 2022-12, Vol.117 (12S), p.S5-S5

2022

Volltextzugriff (PDF)

S3349 Treatment Patterns Among Patients With a History of Moderate to Severe Ulcerative Colitis in CorEvitas’ Inflammatory Bowel Disease Registry

The American journal of gastroenterology, 2021-10, Vol.116 (1), p.S1379-S1380

2021

Volltextzugriff (PDF)

Endoscopic mucosal healing and histologic remission in ulcerative colitis: a systematic literature review of clinical, quality-of-life and economic outcomes

Current medical research and opinion, 2022-09, Vol.38 (9), p.1531-1541

2022

Volltextzugriff (PDF)

107 REAL-WORLD DOSE ESCALATION IN PATIENTS WITH MODERATE-TO-SEVERE ULCERATIVE COLITIS: A SYSTEMATIC REVIEW OF LITERATURE

Gastroenterology (New York, N.Y. 1943), 2021-05, Vol.160 (6), p.S-26-S-26

2021

Volltextzugriff (PDF)

Sa067 ENDOSCOPIC IMPROVEMENT AND HISTOLOGICAL REMISSION IN ULCERATIVE COLITIS: A SYSTEMATIC LITERATURE REVIEW OF CLINICAL, ECONOMIC AND QUALITY OF LIFE OUTCOMES

Gastroenterology (New York, N.Y. 1943), 2021-05, Vol.160 (6), p.S-406-S-406

2021

Volltextzugriff (PDF)

A Systematic Literature Review (SLR) and Meta-Analysis of Clinical Evidence of Second Line or Later (2L+) Treatments for Follicular Lymphoma (FL) in Adult Patients

Blood, 2023-11, Vol.142 (Supplement 1), p.6139-6139

2023

Volltextzugriff (PDF)

EP1029: EVALUATION OF WORK PRODUCTIVITY AND ACTIVITY IMPAIRMENT IN MODERATE-TO-SEVERE ULCERATIVE COLITIS PARTICIPANTS TREATED WITH OZANIMOD IN THE PHASE 3 TRUE NORTH STUDY

Gastroenterology (New York, N.Y. 1943), 2022-05, Vol.162 (7), p.S-1036-S-1037

2022

Volltextzugriff (PDF)

Matching-Adjusted Indirect Comparison (MAIC) of Efficacy and Safety of Lisocabtagene Maraleucel (liso-cel) and Mosunetuzumab for the Treatment (Tx) of Third Line or Later (3L+) Relapsed or Refractory (R/R) Follicular Lymphoma (FL)

Blood, 2023-11, Vol.142 (Supplement 1), p.2338-2338

2023

Volltextzugriff (PDF)

Comparative Efficacy and Safety of Ozanimod and Dimethyl Fumarate for Relapsing-Remitting Multiple Sclerosis Using Matching-Adjusted Indirect Comparison

CNS drugs, 2021-07, Vol.35 (7), p.795-804

2021

Volltextzugriff (PDF)

Patient and Neurologist Preferences in the US for RRMS Treatments: Findings From a Discrete Choice Experiment (1121)

Neurology, 2021-04, Vol.96 (15_supplement)

2021

Volltextzugriff (PDF)

Patient-Reported Outcomes from the MCL Cohort of the Phase 1, Seamless Design TRANSCEND NHL 001 Study of Lisocabtagene Maraleucel in Patients with R/R B-Cell NHL

Blood, 2023-11, Vol.142 (Supplement 1), p.667-667

2023

Volltextzugriff (PDF)

Patient-Reported Outcomes (PROs) from the Phase 2 TRANSCEND FL Study of Lisocabtagene Maraleucel (liso-cel) in Patients (pts) with Relapsed or Refractory Follicular Lymphoma (FL)

Blood, 2023-11, Vol.142 (Supplement 1), p.668-668

2023

Volltextzugriff (PDF)

A Systematic Review of the Economic and Health-Related Quality of Life Impact of Advanced Therapies Used to Treat Moderate-to-Severe Ulcerative Colitis

Advances in therapy, 2023-05, Vol.40 (5), p.2116-2146

2023

Volltextzugriff (PDF)

Systematic Literature Review of Real-World Evidence on Dose Escalation and Treatment Switching in Ulcerative Colitis

ClinicoEconomics and outcomes research, 2023-01, Vol.15, p.125-138

2023

Volltextzugriff (PDF)

Patient and neurologist preferences in the UK for relapsing-remitting multiple sclerosis treatments: findings from a discrete choice experiment

Current medical research and opinion, 2021-09, Vol.37 (9), p.1589-1598

2021

Volltextzugriff (PDF)

Matching-adjusted indirect treatment comparison of ozanimod versus teriflunomide for relapsing multiple sclerosis

Multiple sclerosis and related disorders, 2021-07, Vol.52, p.102972-102972, Article 102972

2021

Volltextzugriff (PDF)

Patient and Neurologist Preferences in the United States for Relapsing-Remitting Multiple Sclerosis Treatments: Findings from a Discrete Choice Experiment

Patient preference and adherence, 2021-01, Vol.15, p.1515-1527

2021

Volltextzugriff (PDF)

Pharmacist-provided medication therapy management (MTM) program impacts outcomes for employees with diabetes

Population health management, 2014-02, Vol.17 (1), p.21-27

2014

Volltextzugriff (PDF)

Improving the economic and humanistic outcomes for diabetic patients: making a case for employer-sponsored medication therapy management

ClinicoEconomics and outcomes research, 2013-01, Vol.5, p.153

2013

Volltextzugriff (PDF)

Improving the economic and humanistic outcomes for diabetic patients: making a case for employer-sponsored medication therapy management

ClinicoEconomics and outcomes research, 2013-01, Vol.5 (default), p.153-159

2013

Volltextzugriff (PDF)

Purification and kinetics of a protease-resistant, neutral, and thermostable phytase from Bacillus subtilis subsp. subtilis JJBS250 ameliorating food nutrition

Preparative biochemistry & biotechnology, 2018-01, Vol.48 (8), p.718-724

2018

Volltextzugriff (PDF)

1 – 24 von 24

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(23)
Mit Volltextzugriff
(12)

Publikationsform

Artikel
(24)

Sprache

Englisch
(24)

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

S3307 Unmet Need of an Oral Treatment in Moderate to Severe Ulcerative Colitis: Findings From International Patient and Physician Survey

S17 Treatment Patterns Among Moderate-to-Severe Ulcerative Colitis Patients in TARGET-IBD

S3349 Treatment Patterns Among Patients With a History of Moderate to Severe Ulcerative Colitis in CorEvitas’ Inflammatory Bowel Disease Registry

Endoscopic mucosal healing and histologic remission in ulcerative colitis: a systematic literature review of clinical, quality-of-life and economic outcomes

107 REAL-WORLD DOSE ESCALATION IN PATIENTS WITH MODERATE-TO-SEVERE ULCERATIVE COLITIS: A SYSTEMATIC REVIEW OF LITERATURE

Sa067 ENDOSCOPIC IMPROVEMENT AND HISTOLOGICAL REMISSION IN ULCERATIVE COLITIS: A SYSTEMATIC LITERATURE REVIEW OF CLINICAL, ECONOMIC AND QUALITY OF LIFE OUTCOMES

A Systematic Literature Review (SLR) and Meta-Analysis of Clinical Evidence of Second Line or Later (2L+) Treatments for Follicular Lymphoma (FL) in Adult Patients

EP1029: EVALUATION OF WORK PRODUCTIVITY AND ACTIVITY IMPAIRMENT IN MODERATE-TO-SEVERE ULCERATIVE COLITIS PARTICIPANTS TREATED WITH OZANIMOD IN THE PHASE 3 TRUE NORTH STUDY

Matching-Adjusted Indirect Comparison (MAIC) of Efficacy and Safety of Lisocabtagene Maraleucel (liso-cel) and Mosunetuzumab for the Treatment (Tx) of Third Line or Later (3L+) Relapsed or Refractory (R/R) Follicular Lymphoma (FL)

Comparative Efficacy and Safety of Ozanimod and Dimethyl Fumarate for Relapsing-Remitting Multiple Sclerosis Using Matching-Adjusted Indirect Comparison

Patient and Neurologist Preferences in the US for RRMS Treatments: Findings From a Discrete Choice Experiment (1121)

Patient-Reported Outcomes from the MCL Cohort of the Phase 1, Seamless Design TRANSCEND NHL 001 Study of Lisocabtagene Maraleucel in Patients with R/R B-Cell NHL

Patient-Reported Outcomes (PROs) from the Phase 2 TRANSCEND FL Study of Lisocabtagene Maraleucel (liso-cel) in Patients (pts) with Relapsed or Refractory Follicular Lymphoma (FL)

A Systematic Review of the Economic and Health-Related Quality of Life Impact of Advanced Therapies Used to Treat Moderate-to-Severe Ulcerative Colitis

Systematic Literature Review of Real-World Evidence on Dose Escalation and Treatment Switching in Ulcerative Colitis

Patient and neurologist preferences in the UK for relapsing-remitting multiple sclerosis treatments: findings from a discrete choice experiment

Matching-adjusted indirect treatment comparison of ozanimod versus teriflunomide for relapsing multiple sclerosis

Lisocabtagene maraleucel in follicular lymphoma: the phase 2 TRANSCEND FL study

Author Correction: Lisocabtagene maraleucel in follicular lymphoma: the phase 2 TRANSCEND FL study

Patient and Neurologist Preferences in the United States for Relapsing-Remitting Multiple Sclerosis Treatments: Findings from a Discrete Choice Experiment

Pharmacist-provided medication therapy management (MTM) program impacts outcomes for employees with diabetes

Improving the economic and humanistic outcomes for diabetic patients: making a case for employer-sponsored medication therapy management

Improving the economic and humanistic outcomes for diabetic patients: making a case for employer-sponsored medication therapy management

Purification and kinetics of a protease-resistant, neutral, and thermostable phytase from Bacillus subtilis subsp. subtilis JJBS250 ameliorating food nutrition

Suchergebnisse filtern